CVE-2006-3240

Description

Cross-site scripting (XSS) vulnerability in classes/ui.class.php in dotProject 2.0.3 and earlier allows remote attackers to inject arbitrary web script or HTML via the login parameter.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.77% Top 30%
Vendor Advisory sourceforge.net
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.vupen.com/english/advisories/2006/2509 vdb entry permissions required
http://secunia.com/advisories/20822 not applicable third party advisory broken link
https://exchange.xforce.ibmcloud.com/vulnerabilities/27585 vdb entry third party advisory broken link
http://dotproject.cvs.sourceforge.net/dotproject/dotproject/classes/ui.class.php?r1=1.113&r2=1.114 patch vendor advisory
http://sourceforge.net/project/shownotes.php?release_id=427236 third party advisory patch
http://www.securityfocus.com/bid/18650 vdb entry third party advisory
http://jvn.jp/jp/JVN%2339188922/index.html third party advisory

Frequently Asked Questions

What is the severity of CVE-2006-3240?
CVE-2006-3240 has been scored as a medium severity vulnerability.
How to fix CVE-2006-3240?
To fix CVE-2006-3240, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-3240 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2006-3240 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.